NICE decides Xolair is not value for money
August 12, 2010Sales and Marketing NICE, Novartis, Xolair
NICE has refused to back the use of Novartis’ Xolair for young children, saying the asthma drug’s cost brings little …
Pharminox promotes Dr Marc Hummersone
August 12, 2010Research and Development Pharminox, appointment, research and development
Nottingham, UK-based cancer drug discovery and development company Pharminox has appointed Dr Marc Hummersone as research director. Marc first joined …
Genzyme posts loss after inventory write-off
August 12, 2010Manufacturing and Production, Sales and Marketing Genzyme, manufacturing compliance
Genzyme has had to write off an additional tranche of product that does not meet quality standards, forcing it to …
Two $1 billion dollar acquisition deals go through
August 11, 2010Sales and Marketing Alcon, M&A, MA, Novartis, Ratiopharm, Teva
Two major acquisition deals mounted by Teva and Novartis are in their final stages as they move to complete potentially …
US biotech investment doubles
August 11, 2010Research and Development biotech, funding
Investment in the beleaguered US biotechnology sector shot up in the second quarter of this year, but analysts say it’s …
Quintiles relocates European headquarters
August 11, 2010Research and Development, Sales and Marketing Quintiles
Contract research organisation and pharma services company Quintiles is moving its European headquarters to Reading in the UK. Previously based …
Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 1
August 11, 2010Research and Development Kinapse, life sciences, pharma
Valuations are essential components of effective transactions in the life sciences industry
Sanofi signs personalised medicine alliance
August 11, 2010Research and Development Sanofi-Aventis, Scripps Genomic Medicine, genomics
Sanofi-Aventis has signed a personalised medicine research alliance with US not-for-profit company Scripps Genomic Medicine. The company is part of …
Sir John Savill to head up MRC
August 11, 2010Research and Development MRC, appointment, research and development
The Medical Research Council has appointed Sir John Savill as chief executive and deputy chair with effect from 1 October. …
Medical Affairs at the centre of life sciences innovation
August 11, 2010Research and Development Kinapse, Medical Affairs
In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …
Lilly sponsors diabetic calendar for Ramadan
August 11, 2010Medical Communications Diabetes UK, disease awareness campaigns, lilly
UK Muslims with diabetes are being offered a special Ramadan calendar that features advice and tips about fasting during the …
Digital Pharma: Novartis rapped for Facebook sharing
August 10, 2010Medical Communications Digital Pharma blog, Facebook, Novartis, Tasigna
Novartis has had its knuckles rapped by the FDA over the company’s use of social media sharing tools. At issue …
WHO delists Sanofi-Aventis combo vaccine
August 10, 2010Manufacturing and Production, Sales and Marketing Sanofi-Aventis, WHO, vaccines
The World Health Organization has dropped a combination vaccine made by Sanofi-Aventis’ subsidiary Shantha Biologics from its list of prequalified …
Bilcare buys INEOS to expand pharma packaging business
August 10, 2010Manufacturing and Production Bilcare, INEOS, Klockner Pentaplast, packaging, pharma packaging
India’s Bilcare will pay 100 million euros to acquire the films business of chemical company group INEOS in a deal …
Capacity expansion helps Hovione to healthy sales increase
August 10, 2010Manufacturing and Production API, Hovione, packaging, pharma packaging
Portuguese active pharmaceutical ingredient manufacturer Hovione has posted a healthy increase in sales for the fiscal year-ended March 31, 2010, …
Elan halts separation plans
August 10, 2010Manufacturing and Production, Research and Development, Sales and Marketing Elan
Irish drugmaker Elan has postponed plans to separate its business into two publicly-listed companies due to adverse market conditions. Elan …
ACM Global expands UK and US teams
August 10, 2010Manufacturing and Production, Research and Development ACM Global, appointment, manufacturing and production, research and development
Clinical services company ACM Global has made several new appointments at its UK and US facilities. Its Global Central Laboratory …
Talking Point: Cost-efficient logistics
August 10, 2010Manufacturing and Production Polar Speed, Talking Point, talking logistics
‘This is an environment where the NHS will face the most severe and substantial financial shortfall in its history,’ Branwen …
AstraZeneca reaches $200m Seroquel settlement
August 10, 2010Sales and Marketing AstraZeneca, Seroquel
AstraZeneca is to pay around £198 million to settle US lawsuits against its troubled anti-psychotic drug Seroquel. The company has …
New Type of Company Launched: Streaming Well created in Europe
August 9, 2010Medical Communications healthcare video, online patient education, streaming well, video distribution
A NEW HEALTHCARE VIDEO PRODUCER AND DISTRIBUTOR PROVIDES INFORMATION AND EDUCATION TO REACH ONLINE AUDIENCES ACROSS EUROPE AND WORLDWIDE.LONDON UK, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
